VIBHAVADI MEDICAL CENTER PUBLIC COMPANY LIMITEDSET: VIBHA🇹🇭 TH

Board Performance · 2025

Prevention of Conflicts of Interest

Has the Company Acted to Prevent Conflicts of Interest?

Yes

Operations in the Past Year

The Board of Directors assigned the Audit Committee to consider transactions that may involve conflicts of interest in accordance with the laws and regulations of the Stock Exchange of Thailand. The Audit Committee was of the opinion that such transactions were normal business transactions of the company. Furthermore, the company's directors and executives strictly adhered to the aforementioned policy. Additionally, during Board meetings, directors with a conflict of interest did not participate in decision-making on significant agenda items. The details of transactions that may involve conflicts of interest have been disclosed under the heading "Connected Transactions".

In 2025, the company received no complaints regarding conflicts of interest.

Number of Conflict-of-Interest Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to conflicts of interest (cases)000

Prevention of the Use of Inside Information

Has the Company Acted to Prevent the Use of Inside Information?

Yes

Operations in the Past Year

The company has established various measures to prevent the disclosure and prevention of transactions that may lead to conflicts of interest, including the misuse of inside information, which could affect the company's business operations. These measures are stipulated in writing in the Corporate Governance Policy, which sets a 30-day blackout period for trading the company's securities and a silent period for directors and executives before the announcement of operating results or quarterly and annual financial statements, as specified in the Business Ethics. Details can be found on the company's website: www.vibhavadi.com/files/ir/corporate-governance/. Furthermore, the company requires its directors and executives to report their securities holdings and changes in securities holdings to the Board of Directors on a quarterly basis.

In 2025, the company found no misconduct related to the use of inside information.

Changes in and holdings of securities by directors and executives are as follows:

Name List

Shareholding in the company

As of Jan 21, 2025

As of Dec 31, 2025

Increase / (Decrease)

  1. Mr. Nikom Wairatpanij

2,150,000

2,150,000

0

  1. Mr. Chaisit Viriyamettakul

2,038,000,000

2,038,000,000

0

  1. Mr. Sirote Sawasdipanich

0

0

0

  1. Mr. Chainarin Sairungsri

0

0

0

  1. Mr. Prasert Sriularpong

0

0

0

  1. Gen. Boonlert Chantrapas

6,260,000

6,260,000

0

  1. Mr. Sitti Panupattanapong

4,500,000

4,500,000

0

  1. Mr. Pitchaya Somboonsin

0

0

0

  1. Mr. Pongpat Pathanavanich

0

0

0

  1. Mr. Pramuk Unachak

100,000,000

100,000,000

0

  1. Mrs. Yada Pattakayon

40,510,143

40,510,143

0

  1. Miss Rukkagee Kanjanapithak

20,510,833

22,198,333

1,687,500

  1. Mr. Phijit Viriyamettakul

473,000,000

478,800,000

5,800,000

  1. Mrs. Bavornphan Ratthaprasert

0

0

0

Note: Data as of book closing date December 31, 2025

Number of Inside-Information Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to the use of inside information to seek benefits (cases)000

Anti-Corruption

Has the Company Acted on Anti-Corruption?

Yes

Operations in the Past Year

The company has announced to directors, executives, and employees at all levels to oppose all forms of corruption. It has also organized anti-corruption orientation for all new employees to acknowledge these guidelines, thereby encouraging all employees to comply. Furthermore, letters have been sent to affiliated companies and business partners to inform them of the anti-corruption policy and practices.

Anti-Corruption: The company received certification as a member of the Thai Private Sector Collective Action Against Corruption (CAC) for the second time on December 30, 2023, from the Thai Institute of Directors Association (IOD). The working group of the Thai Private Sector Collective Action Against Corruption (CAC) held a meeting to summarize the operational results for the year 2025, reviewing the anti-corruption policy and assessing corruption risks. It was found that the policy and manual are consistent with the self-assessment form, and the anti-corruption policy has been communicated to executives and employees, and also through the company's website. www.vibhavadi.com The company also aims to be part of building a network of transparency for a strong Thai society.

Furthermore, the Board of Directors has assigned the Audit Committee to monitor corruption and report the findings to the meeting. The company also provides channels for reporting misconduct and corruption, whether verbally or in writing, through the company's Audit Committee members, to proceed according to the company's established procedures and report to the Board of Directors for consideration. Contact channels are as follows:

1. By mail, sent to:

Audit Committee

Vibhavadi Hospital Public Company Limited 51/3 Ngamwongwan Road, Lat Yao Subdistrict, Chatuchak District, Bangkok 10900

2. By email to the Audit Committee. vibha_cac@vibhavadi.com

3. Via QR-CODE, information will be sent to the Audit Committee.

The company has procedures for considering complaints and measures to protect whistleblowers. The company places importance on keeping information regarding tips or complaints confidential. Details of the procedures and measures can be found on the company's website. https://www.vibhavadi.com/files/ir/corporate-governance/

In 2025, the company received reports regarding non-compliance with company regulations. The Board of Directors appointed an investigation committee to proceed according to the company's investigation steps and processes, and implemented the company's disciplinary actions.

Form of Anti-Corruption Operations

Operation
The participation in anti-corruption projects
Review of appropriateness in anti-corruption
Assessment and identification of corruption risk
Communication and training for employees on anti-corruption policy and guidelines
The monitoring of the evaluation of compliance with the anti- corruption policy
Review of the completeness and adequacy of the process by the Audit Committee or auditor

Number of Corruption Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to corruption (cases)100

Details of Corruption Cases

StatusPeriod TypeStart of PeriodEnd of PeriodDetails of the Case or IssueInvestigation ResultsCorrective Actions
Incident no longer subject to actionmonth/year Range2025-072026-08
Incorrect timekeeping
Comply with company regulations and penalties
Currently, the company has implemented technology to assist in recording working hours, which indicates the individual's location.

Whistleblowing

Has the Company Implemented Whistleblowing Procedures?

Yes

Operations in the Past Year

The Board of Directors has established measures for reporting or complaining about illegal acts, ethical breaches, or behaviors that may indicate corruption or misconduct by individuals within the organization, including employees and other stakeholders. Such acts include inaccurate financial reports or defective internal control systems. The company must also have a mechanism to protect whistleblowers or complainants to enable stakeholders to participate more effectively in overseeing the company's interests.

Matters for Whistleblowing or Complaint

  • Illegal acts, corruption, violations of company regulations, or breaches of ethics by directors and employees

  • Irregularities in financial reports, defective internal control systems

  • Matters affecting the company's interests or reputation

Whistleblowing or Complaint Channels

The Board of Directors provides opportunities for stakeholders to communicate with the Board and will protect the rights of stakeholders who report or complain about various issues. Communication channels are available through the company's Audit Committee to proceed according to the company's established processes and report to the Board of Directors. The contact channels are as follows:

1. By mail, sent to

Audit Committee

Vibhavadi Hospital Public Company Limited 51/3 Ngamwongwan Road, Lat Yao Subdistrict, Chatuchak District, Bangkok 10900

2. Via email to the Audit Committee vibha_cac@vibhavadi.com

3. Via QR-CODE, information will be sent to the Audit Committee

Whistleblower Protection Mechanism

To ensure confidence for whistleblowers or complainants, the company prioritizes keeping whistleblower or complaint information confidential and has established written procedures for receiving and investigating such matters. The complaints will only be known to individuals specifically assigned to them. If such confidential information is disclosed, the company will investigate the person who disclosed it and impose penalties on those who committed the act.

Furthermore, it is the duty of every supervisor or head of department of the whistleblower or complainant to exercise appropriate discretion to protect whistleblowers, complainants, witnesses, and individuals providing information in investigations from danger, distress, or injustice arising from whistleblowing, complaints, testifying, or providing information.

This is in accordance with the policy for protecting and ensuring fairness for employees who report or complain about corruption or non-compliance with laws, regulations, rules, and the company's code of ethics.

The company has procedures for considering complaints and measures to protect complainants. The company prioritizes keeping whistleblower or complaint information confidential. Details of the procedures and measures can be found on the company's website. https://www.vibhavadi.com/th/ir/anti-corruption-and-anti-bribery

Number of Whistleblowing Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues received through whistleblowing channels (cases)000

Selection of Directors & Chief Executives

Selection, Development & Evaluation — Introduction

1) Director Nomination

The Board of Directors has appointed the Nomination and Remuneration Committee to consider the criteria and process for the nomination of directors and senior executives, and to review remuneration, as well as to select qualified individuals to serve as company directors and propose them to the Board of Directors for consideration and nomination to the shareholders' meeting for election, or to propose them to the Board of Directors for further approval.

In 2025, the Company has five directors whose terms are due, in accordance with the Company's Articles of Association, which stipulate that at least one-third of the total number of directors must retire from office. The Nomination and Remuneration Committee considered the qualifications of all five individuals and determined that they possess knowledge, competence, extensive experience, a good work history, leadership qualities, broad vision, as well as ethics and integrity, and a positive attitude towards the organization, enabling them to dedicate sufficient time, which is beneficial to the Company's operations. Furthermore, they meet the qualifications and do not possess any prohibited characteristics under the Public Limited Company Act and the Securities and Exchange Act B.E. 2535 (1992) (including any amendments thereof), as well as relevant notifications. Therefore, it is proposed that they be re-appointed as directors of the Company for another term.

Regarding the election of directors by the shareholders' meeting, the Company allows shareholders to cast votes for the election of directors on an individual basis, and the appointment of directors shall be approved by a majority vote at the meeting.

Directors & Chief Executives — Introduction

1. Recruitment of Directors and Senior Executives

Director Recruitment

For the recruitment of directors, the company has appointed a Nomination and Remuneration Committee to consider, select, propose, and verify suitable individuals for vacant director positions. The company also provides an opportunity for minority shareholders to nominate individuals they deem qualified for selection as company directors each year, through an announcement on the company's website. Furthermore, the committee considers proposing directors whose terms have expired for re-appointment to the Board of Directors. The appointment of directors adheres to the following principles and procedures:

1. In the election of directors, each shareholder shall have one vote per share.

2. In the election of directors, votes shall be cast for individual candidates. Shareholders shall cast all their available votes for one nominated director at a time.

3. Individuals who receive the highest votes in descending order shall be elected as directors, up to the number of directors to be elected at that time. In the event that individuals in the subsequent order of election receive an equal number of votes, exceeding the number of directors to be appointed, the Chairman of the meeting shall cast an additional vote as a tie-breaker.

In the event that a director position becomes vacant for reasons other than the expiration of their term, the Board of Directors shall consider appointing an individual who possesses the qualifications and does not have any prohibited characteristics as stipulated by law to fill the vacancy at the next Board meeting, unless the remaining term of the vacating director is less than 2 months. The individual appointed to fill the vacancy shall hold the director position only for the remaining term of the director they replace. Furthermore, the resolution for appointing such an individual to fill a vacancy must receive no less than three-fourths of the votes of the remaining directors.

Recruitment of Senior Executives

Recruitment of executives and senior executives: The Nomination and Remuneration Committee shall consider selecting from current executives or other individuals with knowledge and ability in management, who possess suitable qualifications, a thorough understanding of the company's business, demonstrate leadership and experience in organizational leadership, are capable of managing operations to achieve the objectives and goals set by the Board of Directors, and who do not possess any prohibited characteristics as stipulated by law. These candidates will then be presented to the Board of Directors meeting for consideration and appointment.

Are Directors Selected Through the Nomination Committee?

Yes

Are Chief Executives Selected Through the Nomination Committee?

Yes

Rights of Minority Shareholders on Director Appointment

The Board of Directors places importance on the rights and equitable treatment of shareholders. This is clearly stipulated in the Company’s Corporate Governance Policy, which grants shareholders the right to propose agenda items and nominate qualified candidates for election as directors at the Annual General Meeting of Shareholders (AGM). In addition, shareholders are given the opportunity to submit questions regarding the Company or the meeting agenda in advance of the AGM to facilitate the exercise of their rights.

The Company has published the details and criteria for exercising such rights on its website at https://www.vibhavadi.com/th/ir/shareholders under the Investor Relations section, as well as through the Stock Exchange of Thailand’s information disclosure system, to ensure that shareholders and investors are well informed. The details are as follows:

1. The Company provides minority shareholders with the opportunity to propose matters they consider important for inclusion in the AGM agenda and to nominate individuals with appropriate qualifications, knowledge, and expertise for election as directors in advance of the AGM. The criteria and procedures are published in both Thai and English on the Company’s website and through the Stock Exchange of Thailand’s news system.

2. The Company notifies shareholders of the AGM schedule in advance to allow them sufficient time to arrange their attendance.

3. The Company publishes the AGM invitation notice and supporting documents, such as the Form 56-1 One Report, on its website. These documents contain the same information as those delivered to shareholders, enabling convenient and timely access and allowing shareholders more time to review the information in advance.

4. The Company publishes the notice of the shareholders’ meeting in newspapers for three consecutive days at least three days prior to the meeting date, namely on 23, 24, and 25 April 2025.

5. The documents delivered to shareholders include the AGM invitation notice containing detailed agenda items with facts, reasons, and the Board’s opinions for each agenda item, together with supporting documents for consideration and voting. These include the Form 56-1 One Report in QR Code format; profiles of nominees for election as directors in place of those retiring by rotation; the definition of independent directors; information on nominated auditors; information on independent directors proposed as proxy holders; the Company’s Articles of Association relating to shareholders’ meetings; required documents and evidence for meeting attendance; meeting procedures; proxy procedures and forms; guidelines for submitting questions in advance; meeting attendance procedures; a map of the meeting venue; a registration form; and proxy forms (Form B, which allows shareholders to specify voting directions, or alternatively Form A or Form C), all of which are available for download on the Company’s website.

Granting Shareholders the Rights to Propose Additional Agenda Items, Nominate Candidates for Election as Directors, and Submit Questions in Advance Prior to the Annual General Meeting of Shareholders for the Year 2025

AGM Date: April 28, 2025

( Physical )

Period for proposing agenda items and nominating director candidates:
5 November 2024 – 17 February 2025

Period for submitting questions in advance:
5 November 2024 – 17 February 2025

Remark: No submissions were received from shareholders.

In 2025, the Company scheduled the Annual General Meeting of Shareholders (AGM) on Monday, 28 April 2025 at 1:30 p.m. at the Conference Room, 9th Floor, Building 4, Vibhavadi Hospital, No. 51/3 Ngamwongwan Road, Lat Yao Subdistrict, Chatuchak District, Bangkok 10900. The Company conducted the meeting in accordance with the AGM Checklist of the Thai Investors Association, the Thai Listed Companies Association, and the Securities and Exchange Commission (SEC), to ensure that shareholders were able to attend and raise questions.

  1. To facilitate shareholders, the Company provided registration one hour prior to the meeting. Shareholders were also allowed to register and attend the meeting at any time during the meeting to exercise their voting rights on agenda items that had not yet been resolved. After the meeting, shareholders could request to review voting details.

  2. Prior to the meeting, the Chairman of the Board, acting as the Chairman of the meeting, assigned directors and the Company Secretary to inform attendees of the voting procedures for each agenda item. During the meeting, shareholders were given the opportunity to raise questions, provide suggestions, and express opinions on all agenda items. The Chairman and management addressed all inquiries clearly and appropriately.

  3. The Company utilized a barcode system for registration and vote counting to facilitate convenience and ensure an efficient and orderly meeting process.

Equitable Treatment of Shareholders

All shareholders are treated equally without discrimination. The Company has clear policies prohibiting the misuse or disclosure of inside information, and requires directors with conflicts of interest to abstain from related agenda items. No misuse has been found.

Conflicts of interest are managed fairly through disclosure, confidentiality, abstention, or other appropriate measures. The Company has established policies and procedures for related party transactions, and requires directors and executives to report changes in securities holdings to the SEC in accordance with Section 59, with such matters reported at every Board meeting.

Proposal of Agenda Items and Nomination of Director Candidates

The Company allows shareholders to propose additional agenda items and nominate qualified candidates for election as directors within appropriate conditions, timeframes, and in compliance with applicable laws.

For the 2025 AGM, shareholders were invited to submit proposals in advance from 5 November 2024 to 17 February 2025, with clear criteria and procedures disclosed via the Stock Exchange of Thailand’s news system and the Company’s website.

Voting Rights, Proxy Appointment, and Voting Procedures

For the 2025 AGM, the Company prioritized the safety and well-being of shareholders by providing adequate staff support, appropriate meeting arrangements, and safety measures, including opening registration one hour in advance to reduce congestion.

Shareholders unable to attend in person may appoint a proxy or an independent director to attend and vote on their behalf, with names specified in the proxy form as prescribed by the Ministry of Commerce. Proxies are treated with the same rights as shareholders. Proxy forms were made available on the Company’s website at least 14 days prior to the meeting. Voting ballots were provided for

Method of Director Appointment

Method
Method whereby each director requires approval votes more than half of the votes of attending shareholders with voting rights

Selection of Independent Directors

Criteria for Selecting Independent Directors

Independent Directors

The Board of Directors has appointed the Nomination and Remuneration Committee. Serves to recruit directors and independent directors. The good corporate governance policy and business ethics stipulate that the Board of Directors must comprise at least one-third of all directors as independent directors, but not less than 3 persons. Independent directors must be independent from the control of management and major shareholders, and must not have any financial or management involvement or interests in the business. Furthermore, they must fully meet the qualifications for independent directors as specified in the Capital Market Supervisory Board Notification No. TorJor. 28/2551 Re: Application for and Approval of New Share Offerings (“Notification TorJor. 28/2551”), including any amendments thereto.

The company has stipulated that independent directors must possess the following qualifications:

1. Holds shares not exceeding one percent of the total voting shares of the major company, subsidiary, associated company, major shareholder, or controlling person of the applicant. This includes the shareholding of related persons of that independent director.

2. Is not or has not been an executive director, employee, regular salaried advisor, or controlling person of the company, major company, subsidiary, associated company, same-tier subsidiary, major shareholder, or controlling person of the company, unless such status has ceased for at least two years prior to the date of appointment. However, this prohibition does not include cases where the independent director was a government official or an advisor to a government agency that is a major shareholder or controlling person of the company.

3. Is not a person related by blood or legal registration as a father, mother, spouse, sibling, or child, including the spouse of a child, of other directors, executives, major shareholders, controlling persons, or individuals proposed to be directors, executives, or controlling persons of the company, major company, or subsidiary.

4. Has no or has not had a business relationship with the company, major company, subsidiary, associated company, major shareholder, or controlling person of the applicant in a manner that may impede their independent judgment, and is not or has not been a significant shareholder or controlling person of those who have a business relationship with the company, major company, subsidiary, associated company, major shareholder, or controlling person of the applicant, unless such status has ceased for at least two years prior to the date of appointment.

Business relationships under the first paragraph include ordinary commercial transactions for business operations, real estate leasing or rental, transactions related to assets or services, or the provision or receipt of financial assistance through lending or borrowing, guarantees, or the pledging of assets as collateral for debts, as well as other similar circumstances, which result in the applicant or counterparty having a debt obligation to the other party of three percent or more of the company's net tangible assets or twenty million baht or more, whichever is lower. The calculation of such debt obligations shall be in accordance with the method for calculating the value of connected transactions as stipulated in the Capital Market Supervisory Board's notification regarding criteria for connected transactions, mutatis mutandis. However, when considering such debt obligations, debts incurred within one year prior to the date of the business relationship with the same person shall be included.

5. Is not or has not been an auditor of the company, major company, subsidiary, associated company, major shareholder, or controlling person of the applicant, and is not a significant shareholder, controlling person, or partner of an audit firm where the auditor of the applicant, major company, subsidiary, associated company, major shareholder, or controlling person of the applicant is affiliated, unless such status has ceased for at least two years prior to the date of appointment.

6. Is not or has not been any professional service provider, including legal or financial advisors, who received service fees exceeding two million baht per year from the company, major company, subsidiary, associated company, major shareholder, or controlling person of the applicant, and is not a significant shareholder, controlling person, or partner of such professional service provider, unless such status has ceased for at least two years prior to the date of appointment.

7. Is not a director appointed as a representative of the company's directors, major shareholders, or shareholders related to major shareholders.

8. Does not engage in a business of the same nature that is significantly competitive with the business of the company or its subsidiaries, or is not a significant partner in a partnership, or an executive director, employee, regular salaried advisor, or holds shares exceeding one percent of the total voting shares of another company that engages in a business of the same nature and is significantly competitive with the business of the applicant or its subsidiaries.

9. Possesses no other characteristics that would prevent them from providing independent opinions regarding the company's operations.

The company has criteria for selecting independent directors from individuals who possess the aforementioned qualifications, as well as knowledge, abilities, skills, and experience beneficial to the company's operations.

During the past accounting period, the company's independent directors had no business relationships or professional service engagements exceeding the criteria specified in the Capital Market Supervisory Board's notification regarding the application for and approval of new share offerings. Furthermore, no independent director holds directorships in more than 5 listed companies.

Did Any Independent Director Have a Business or Professional Relationship?

No

Director Development

Development of Directors in the Past Year

All members of the company's Board of Directors possess knowledge, capabilities, experience, and expertise beneficial to the company, as well as being well-informed, understanding, and responsible for the company's business operations. Nevertheless, the Board of Directors also recognizes and is committed to participating in, supporting, and providing opportunities for relevant stakeholders to attend various courses that are deemed continuously beneficial to the company.

Evaluation of Board & Subcommittee Performance

Criteria for Evaluating Board Performance

The company has stipulated that the Board of Directors and sub-committees be evaluated once a year. Guidelines from the Stock Exchange of Thailand have been adapted to suit the nature and structure of the Board in preparing the evaluation forms. There are two types of evaluation forms:

  1. Board Self-Assessment: An evaluation of the performance of the entire Board of Directors is conducted, divided into 5 aspects:

1. Board Structure

2. Board Meetings

3. Roles, Duties, and Responsibilities of the Board

4. Relationship with Management

5. Self-Development of Directors and Executive Development

2. Individual Director Self-Assessment: An evaluation of the performance of the entire Board of Directors is conducted, divided into 3 aspects:

1. Board Structure

2. Board Meetings

3. Roles, Duties, and Responsibilities of the Board

The evaluation criteria are calculated as a percentage of the full score for each item, as follows:

Criteria

Score

Excellent

90% or above

Very Good

80% or above

Good

70% or above

Below Criteria

Below 70%

The performance evaluation of the Board of Directors and sub-committees is conducted annually. The scores and feedback from directors will be used to improve the performance of the Board each year and to enhance the effectiveness of the Board's work. The Company Secretary distributes the overall Board performance evaluation form and individual director performance evaluation forms to all directors. All directors have independence in completing these evaluation forms. Once completed, the forms are to be returned to the Company Secretary for compilation, summarization of results, and reporting to the Board of Directors at Board meetings.

In 2025, the overall evaluation results for the Board of Directors as a whole were rated "Excellent" with an average score of 94.21%, and the overall evaluation results for individual directors were rated "Excellent" with an average score of 96.75%.

Evaluation of Board Performance in the Past Year

The company has stipulated that the Board of Directors and sub-committees shall be evaluated annually, once a year, to collect and summarize the evaluation results, and to utilize the obtained information to review and effectively develop their performance of duties, and report to the Board of Directors for acknowledgment.

Evaluation Results

Evaluated BodyGroup — Carried Out?Group — Grade / Average ScoreGroup — Grade / Full ScoreIndividual (Self-Assessment) — Carried Out?Individual (Self-Assessment) — Grade / Average ScoreIndividual (Self-Assessment) — Grade / Full ScoreCross (Assessing Other Directors) — Carried Out?
Executive CommitteeY97.60100Y97.60100N
Other SubcommitteeY98.20100Y98.20100N
Audit CommitteeY85.5100Y85.5100N
Other SubcommitteeY97.67100Y97.67100N
Other SubcommitteeY98100Y98100N
Board Of DirectorY94.21100Y94.21100N

Subcommittees

Subcommittees

Results of the Subcommittee's Duty Performance

In 2025, the Nomination and Remuneration Committee held 2 meetings to consider various matters and report the meeting results along with recommendations to the Board of Directors for consideration. The key matters considered are summarized as follows:

1. Recruit and propose suitable candidates for the Board of Directors and sub-committees to replace directors whose terms have expired, based on their knowledge, abilities, and experience relevant to the Company's business, for the Board of Directors to consider and propose to the shareholders' meeting for approval. The Company has provided an opportunity for shareholders to nominate individuals for consideration as directors in advance of the 2025 Annual General Meeting of Shareholders, from November 5, 2024, to February 17, 2025.

2. Consider the remuneration for the Board of Directors and sub-committees. The criteria for determining directors' remuneration are based on financial performance, operational results, directors' authority and responsibilities, the Company's growth and performance, business liquidity, and the performance of each individual director. This is benchmarked against businesses of the same or similar type as the Company, for the Board of Directors to consider and propose to the shareholders' meeting for approval.

3. Review the succession plan for senior executives and key positions within the Company to ensure continuous and efficient performance in those positions, driving the organization towards sustainable growth in the future. This involves retaining high-potential personnel to contribute to the organization's success, as well as developing high-potential personnel within the organization to advance into senior executive roles in their respective fields through systematic and continuous development processes.

4. Review the charter of the Nomination and Remuneration Committee to ensure compliance with relevant criteria, roles, and responsibilities for operational efficiency.

The Nomination and Remuneration Committee performed its assigned duties with due care, prudence, transparency, fairness, and provided straightforward opinions, in accordance with good corporate governance principles, prioritizing the utmost benefit of all stakeholders.

In 2025, the Risk Management and Investment Committee held 3 meetings to consider and provide opinions on the organization's risk assessment. The key matters considered are summarized as follows:

  1. Reviewed the annual Risk Management Policy for 2025. The policy is consistent with actual operations and current circumstances, as discussed at the 3rd/2025 meeting held on December 22, 2025.

  2. Considered the company's significant risks aligned with its business operations, such as investment, financial, safety, legal, and regulatory aspects. Recommendations were made on prevention methods and ways to reduce risk levels to an acceptable degree. Furthermore, performance was monitored and evaluated, and operational plans were adjusted for continuous risk reduction and to suit the prevailing business conditions.

  3. The Risk Management Committee held discussions with the Audit Committee regarding significant risks to ensure that the company has appropriate internal control systems. Notably, the Risk Management Committee includes members who are also Audit Committee members.

  4. The Risk Management and Investment Committee monitored investments and reported to the Board of Directors quarterly.

The Risk Management and Investment Committee is of the opinion that during the past year 2025, the company has managed risks to cover all risk factors, continuously monitored and prevented risks, and in line with changing circumstances, to promptly consider significant and urgent risks, which leads to effective risk management and for the sustainable benefit of the company's stakeholders.

In 2025, the Governance and Sustainability Committee held 2 meetings to oversee, monitor, and evaluate performance according to the good corporate governance, anti-corruption, and sustainability plans, as well as to acknowledge recommendations for developing corporate governance and sustainability for the 2025 CGR and SET ESG Ratings evaluations from the Thai Institute of Directors (IOD) and the Stock Exchange of Thailand. The summary report of duties performed according to good corporate governance principles includes the following key duties:

  1. Oversee the establishment of criteria for providing opportunities for minority shareholders to propose meeting agendas and nominate individuals for consideration as company directors in advance of the 2025 Annual General Meeting of Shareholders, from November 5, 2024, to February 17, 2025.

  2. Oversee the performance evaluation of the Board of Directors and sub-committees, both collectively and individually, for the year 2025, and disclose the evaluation results in the Annual Information Form/Annual Report (Form 56-1ne Report). The 2025 Board evaluation result was 94%, indicating an excellent level.

  3. Consider the charter, sustainability policy, and key sustainability issues, along with setting operational targets for each issue and defining sustainability strategies, as resolved at the 2/2025 Governance and Sustainability Committee Meeting held on December 16, 2025.

  4. Monitor the results of complaints and non-compliance with the business ethics. In 2025, no significant complaints or tip-offs related to violations of business ethics, anti-corruption policies, or human rights abuses were found.

In 2025, the company was selected for the SET ESG Ratings 2025 in the A level by the Stock Exchange of Thailand, received an "Excellent" rating in the Corporate Governance Report of Thai Listed Companies (CGR) from the Thai Institute of Directors (IOD) and the Stock Exchange of Thailand, and was certified as a member of the Collective Action Against Corruption (CAC), demonstrating the company's commitment to sustainable business development.

The Governance and Sustainability Committee is committed to good corporate governance, conducting business fairly and with environmental consciousness, taking into account all stakeholders. Furthermore, it is dedicated to enhancing the company's operational efficiency to meet international standards for sustainable growth.

Meeting Attendance & Remuneration

Meeting Attendance — Sub-section Introduction

In 2025, the Company has scheduled Board of Directors meetings four times a year in advance, with additional special meetings convened as necessary. Directors are obligated to attend all meetings, unless there is a compelling reason. The Company Secretary is assigned to determine the dates for Board meetings in advance each year to enable directors to manage their time and ensure their attendance. Furthermore, the Company Secretary is responsible for recording and preparing written minutes of the meetings, ensuring they are complete, accurate, and clear, encompassing both the meeting outcomes and the directors' opinions. The minutes approved by the Board of Directors, along with meeting invitations and supporting documents, will be stored by the Company Secretary in both physical and electronic formats in a secure location. These documents will be readily available for retrieval or inspection exclusively by the Board of Directors or other authorized and relevant individuals.

Types of Remuneration of the Board of Directors

Director Remuneration

The company has established appropriate director remuneration, comparable to that of companies in the same industry. Factors considered include duties, scope, roles, and responsibilities. Director remuneration will vary according to the company's annual performance. The payment of director remuneration must be approved by the shareholders' meeting.

Director remuneration for the year 2025 has been approved by the shareholders' meeting as follows:

Item

Year 2024 (Baht)

Year 2025 (Baht)

1. Director Bonuses

5,250,000.00

5,250,000.00

2. Remuneration for the Chairman of the Board

1,560,000.00

1,560,000.00

3. Board Meeting Allowances

3,000,000.00

3,000,000.00

4. Remuneration for Audit Committee Members

960,000.00

960,000.00

5. Other Benefits

None

None

Total

10,770,000.00

10,770,000.00

Remuneration of the Board — Introduction

Details of remuneration for directors entitled to receive individual remuneration, based on information of the current Board of Directors as of December 31, 2025.

Remuneration or Benefits Payable to the Board

MetricAmount (Baht)
Remunerations or benefits pending payment to the board of directors over the past year (baht)0

Supervision of Subsidiaries & Associated Companies

Does the Company Have Subsidiaries or Associated Companies?

Yes

Is There a Mechanism for Overseeing Subsidiaries and Associated Companies?

Yes

Mechanism for Overseeing Management of Subsidiaries

Supervision of subsidiaries and associated companies. The Company has appointed directors and executives to serve as directors in all subsidiaries. These directors and executives have been approved by the Company's Board of Directors to closely supervise operations and to establish key policies for business operations. Additionally, appropriate and sufficient internal controls are implemented, and resolutions on significant matters must always receive approval from the Company's Board of Directors. The boards of directors of subsidiaries must report their operational results to the Executive Committee monthly and to the Company's Board of Directors every three months. Regarding the supervision of information disclosure and connected transactions, subsidiaries comply with the rules and regulations of the Stock Exchange of Thailand, similar to the parent company.

Oversight Mechanisms

Mechanism
Sending representatives to act as directors, executives or controlling persons in proportion to shareholdings

Board Duty Performance — Overview

Board Duty Performance — Overall Description

The company conducts its business and operations under the supervision of the Board of Directors, committed to upholding business ethics in operating with fairness and responsibility towards all stakeholders, in accordance with the principles of good corporate governance for listed companies in 2560 by the Securities and Exchange Commission, or the Corporate Governance Code (CG Code), business ethics, and anti-corruption policy, and considering social and environmental impacts to build confidence among shareholders, investors, and stakeholders, foster a positive organizational culture and values, support favorable business performance for the company, and enhance competitiveness and sustainable growth.

The company has reviewed its charter, policies, measures, and various practices in organizational management in accordance with good corporate governance principles and international standards. The company has also published its corporate governance policy and business ethics to serve as a guideline for all directors, executives, and employees, and to allow investors, interested parties, and stakeholders to access and read them on the company's website. https://www.vibhavadi.com/th/ir/corporate-governance

In 2568, the company undertook the following actions to promote, develop, monitor, and assess corporate governance:

  1. Review of the Corporate Governance Policy and Business Ethics. It is stipulated that a review be conducted once a year. At the 2/2568 meeting of the Corporate Governance and Sustainability Committee on December 16, 2568, the said policy was found to be consistent with current operations and will be presented to the Board of Directors' meeting for further consideration.

  2. Review of the annual strategic plan and monitoring of performance from the past year.

  3. Approved principles and guidelines for succession planning to strategically recruit and select qualified personnel in line with the company's strategy, to fill critical positions or positions that will be vacated due to retirement or future openings, and to ensure operational continuity and mitigate the risk of disruption in operations.

  4. The company monitors and evaluates compliance with policies and ethics in its annual assessment in the year 2568 No violations or complaints were found.

  5. Training on company policies, business ethics, anti-corruption, operational guidelines, and other relevant topics is provided through new employee orientation.

Corporate Governance Assessment Results

  1. Thai Listed Companies Corporate Governance Report (CGR) Survey. The company received a CGR assessment score for the year 2568 at the level of "Excellent"

  2. SET ESG Ratings Sustainable Stock Assessment Project. The company was assessed to be in the sustainable stock group for the year 2568 (SET ESG Ratings) by the Stock Exchange of Thailand at the level of "A" Demonstrates a commitment to conducting business with consideration for environmental, social, and governance (ESG) impacts to foster sustainable growth.

  3. Participation in the Thai Private Sector Collective Action Against Corruption (CAC) project. The company has been certified as a member of the Thai Private Sector Collective Action Against Corruption (CAC). "for the second time"

  4. Shareholder Meeting Quality Assessment Project (AGM Checklist). The company received an assessment of the quality of its Annual General Meeting of Shareholders for the year 2568 at the level of "5 stars" from the Thai Investors Association

  5. The company received ISO 9001:2015 quality system certification from SGS (Thailand) Limited.

Audit Committee Duty Performance

Results of the Audit Committee's Duty Performance in the Past Year

The Audit Committee of Vibhavadi Medical Center Public Company Limited consists of 4 independent directors who possess competence and experience, and fully meet the qualifications specified in the Audit Committee Charter and the regulations of the Stock Exchange of Thailand. They have performed their duties independently within the scope of authority and responsibilities assigned by the Board of Directors. The Audit Committee comprises:

1. Mr. Sirote Sawasdipanich Chairman of the Audit Committee

2. Mr. Nikom Wairatpanij Audit Committee Member

3. Mr. Prasert Sriurapong Audit Committee Member

4. Mr. Chainarin Sairungsri Audit Committee Member

Mr. Techanat Sriratchadakorn serves as the Head of the Internal Audit Department and acts as the Secretary to the Audit Committee.

During the year 2025, the Audit Committee held 9 meetings, with all Audit Committee members attending every meeting. At the end of each year, the Audit Committee evaluates its performance, with evaluation topics including structure and qualifications, roles and responsibilities, performance and meetings, overall opinion, performance of the Audit Committee Secretary, and performance of the Internal Audit Department. A summary of the Audit Committee's key duties, opinions, and reports on various matters to the Board of Directors during the year is as follows:

  1. Review of the financial statements of the company and its subsidiaries: The Audit Committee reviewed the quarterly financial statements and the annual financial statements for 2025, including related party transactions and transactions that may have conflicts of interest. Relevant management and the auditor were invited to attend meetings for the consideration of financial statements to provide explanations and answer questions from the Audit Committee. The Audit Committee is of the opinion that the financial statements are presented fairly in all material respects in accordance with financial reporting standards. Furthermore, meetings were held with the auditor without the presence of management to allow for independent exchange of information and opinions.

  2. Review and assessment of the adequacy of the internal control system: The Audit Committee reviewed the internal control system from the Internal Audit Department, as well as the adequacy of the internal control system according to guidelines set by the Securities and Exchange Commission of Thailand. The Audit Committee regularly reported its findings and opinions to the Board of Directors and management. The Audit Committee is of the opinion that the company has an appropriate, effective, and sufficient internal control system to prevent operational risks in line with the company's various policies and strategies.

  3. The Audit Committee approved the topics and scope of internal audit operations and the annual audit plan for 2025. In 2025, the company's internal audit unit audited and evaluated the company's internal control system by reviewing internal audit reports and monitoring corrective actions based on these reports. It also provided recommendations for improving audit efficiency, the independence of the internal audit function, and considered the appropriateness of the budget, staffing levels, personnel training and development, and the annual performance evaluation of the Head of Internal Audit. The Audit Committee is of the opinion that the company has an appropriate and effective internal audit system.

  4. Review of the company's compliance with securities and exchange laws, stock exchange regulations, and laws related to the company's business: The Audit Committee reviewed the company's operations to ensure compliance with securities and exchange laws, regulations of the Stock Exchange of Thailand, and laws related to the company's business, as well as reviewed good corporate governance processes to promote operations that are correct, transparent, and auditable.

  5. Consideration of connected transactions or transactions that may have conflicts of interest: In compliance with laws and regulations of the Stock Exchange, the Audit Committee reviewed and provided opinions on connected transactions or transactions that may have conflicts of interest, as disclosed by management in such transactions, in accordance with the regulations of the Stock Exchange of Thailand and the Securities and Exchange Commission. The Audit Committee is of the opinion that these transactions are beneficial to the company and that material transactions have been accurately and completely disclosed and presented in the financial statements and notes to the financial statements.

  6. Consideration for Selection and Proposal for Appointment of Auditor: The Audit Committee considered the performance, knowledge, understanding of the company's business, qualifications of the auditor, and the appropriateness of the audit fees. Therefore, it deemed appropriate to propose the appointment of Dharmniti Auditing Co., Ltd. as the annual auditor and to propose the annual remuneration to the Board of Directors for submission to the Shareholders' Meeting for approval.

  7. Performance Evaluation and Charter Review: The Audit Committee reviewed itself, both as a committee and individually, and reviewed the charter to ensure that the Audit Committee Charter remains appropriate and consistent with the regulations of the Stock Exchange of Thailand, and proposed it for consideration and approval by the Board of Directors.

  8. Consideration for Review of the Internal Audit Department Charter: The Audit Committee reviewed the Internal Audit Department Charter to ensure that the roles, duties, powers, responsibilities, and independence of the Internal Audit Department are clearly defined, appropriate, and consistent with good corporate governance principles, as well as relevant criteria and practices.

The Audit Committee has performed its duties in accordance with the Audit Committee Charter and the responsibilities assigned by the Board of Directors with due care, prudence, and to its full capacity. The Audit Committee is of the opinion that the company has an adequate and appropriate internal control system, reliable and accurate financial reporting in accordance with generally accepted accounting standards and relevant financial reporting standards, sufficient disclosure of connected transactions and material information, adherence to good corporate governance principles, and continuous development and improvement of the quality of its internal control system.

Executive Committee Duty Performance

Results of the Executive Committee's Duty Performance in the Past Year

In 2025, the company held 12 Executive Board meetings and managed various important matters as follows:

1. In terms of business administration and development, the company has developed specialized medical centers and specialized treatment services, such as establishing the Siam Gamma Knife Therapy Center. The first and only neuro-radiosurgery center in Thailand utilizing technology Leksell Gamma Knife which is a global standard for treating brain and nervous system diseases without open surgery, and officially opened its clinic on 16 June 2025

2. In terms of facility improvement, the company has improved its service areas, such as renovating the Health and Occupational Health Center, patient rooms, and patient family waiting rooms, to facilitate service users. Additionally, the company received the Outstanding Building Safety Award (25-Year Building). (BSA Building Safety Award 2025) receiving a “Silver” award from the Department of Public Works and Town & Country Planning.

3. In terms of information technology, the company has adopted technology to assist in asset management, enabling faster tracking of asset status.

4. In terms of image, the company received the "Thailand's Most Admired Company 2024 - 2025" award, ranking 6th in the private hospital group, as ranked by BrandAge magazine.

5. In terms of corporate governance, the Executive Board has monitored the performance of the company and its subsidiaries monthly to mitigate and/or prevent potential risks, as well as to find solutions that are most beneficial to the company, including emphasizing environmental and social aspects. As a result, the company received the following assessments:

- Received a "5-star" CGR assessment for 2025 from the Thai Institute of Directors Association (IOD).

- Received an "A" group ESG Rating for 2025 from the Stock Exchange of Thailand (SET).

- Certified as a member of the Thai Private Sector Collective Action Against Corruption for the 12th time.

- Received an "Excellent" (5-star) rating in the 2025 AGM Checklist assessment from the Thai Investors Association (TIA).

- Certified as a hospital capable of meeting the Green & Clean Hospital Challenge standards at an "Excellent" level by the Department of Health, Ministry of Public Health.

Contents